NHS Tracker: Find out about hospital waiting times in your area this winter

As the weather gets warmer, pants turn to shorts, long sleeves turn to tank tops and sensible waterproof winter boots turn to cute strappy sandals. If you’re planning on showing your feet to the world or have a sunny vacation on the calendar, you’re likely in dire need of a pedicure. Before you make an…

The world is aging rapidly, and there are more and more ways to invest in this theme. Shams Afzal, managing director at Carnegie Investment Counsel, noted that 17% of the U.S. population is now over the age of 65, and that proportion is expected to grow higher. And the demographics of that age group is…

The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…

Twenty million Americans signed up for affordable health insurance for 2024, breaking an enrollment record under the Affordable Care Act for the third consecutive year, the Centers for Medicare & Medicaid Services announced Wednesday. “With six days left to still get covered, 8 million more Americans have signed up for ACA coverage than when I took office,”…

Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday,…